loder

Europe Clinical Nutrition Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

Europe Clinical Nutrition Market - By Route of Administration: Enteral Nutrition (EN), Parenteral Nutrition (PN), Oral Nutritional Supplements (ONS); By End User: Hospitals and Acute Care Centers, Home Healthcare & Long-Term Care, Specialized Outpatient Clinics; By Country: Germany, United Kingdom, France, Spain, Italy, Russia, Rest of Europe

Report Code
CVMI24072747
Published
July 16, 2024
Last Updated
July 16, 2024
Coverage
Healthcare • Healthcare IT
Analyst-led, consultative delivery
Enterprise-ready licensing options
Fast turnarounds for custom cuts

Market Snapshot

High-signal KPIs designed for executive scanning.
Indicative snapshot. Request sample for full model outputs.
Market Size (latest)
vs. prior year
CAGR
Forecast window:
Forecast Period
2024–2031
Base years: 2019–2023
Coverage Depth
Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.

Market Overview:

The European clinical nutrition market is undergoing a significant transformation, driven by an aging population, a rise in the burden of chronic diseases, and increased awareness of malnutrition in clinical settings. Hospitals in Germany, France, the UK, Italy, and the Netherlands are actively integrating nutrition into patient recovery pathways. Additionally, home-based enteral and parenteral nutrition services are expanding across the continent, supported by national health insurance programs and digital monitoring technologies.

 

Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

11.8

Covers both hospital-based and home-administered nutrition solutions

2024

17.6

CAGR 8.4% (2019–2024); driven by elderly care and cancer nutrition protocols

2031

26.4

CAGR 5.9% (2024–2031); digital support tools and renal/GI formulations rise

 

Market Drivers

  • Aging demographic in Western and Southern Europe necessitating tailored nutritional support
  • Implementation of standardized screening tools (MUST, NRS-2002) across hospital systems
  • Rise in cancer, diabetes, renal, and gastrointestinal disease cases requiring therapeutic nutrition
  • EU-wide guidelines encouraging perioperative and ICU-specific nutritional interventions
  • Strong R&D and manufacturing presence of firms like Fresenius Kabi, Nestlé Health Science, and Danone Nutricia

 

Market Challenges

  • Public hospital budget constraints limiting advanced nutrition product access
  • Regulatory variation between EU member states for product approval and reimbursement
  • Low nutritional screening rates in outpatient and rehabilitation care
  • Cultural differences in adoption of tube feeding and parenteral nutrition at home

 

Competitive Landscape

Company

2024 Share

Key Focus Areas

Recent Developments

Nestlé Health Science

22%

Adult enteral, GI, and oncology nutrition

Launched GI Protect+ in EU (Q1 2025)

Danone Nutricia

20%

Renal, pediatric, and home nutrition solutions

New renal-focused blends in Italy & Germany (2024)

Fresenius Kabi

17%

Parenteral nutrition, ICU, and oncology

Expanded lipid-based IV product line (Q2 2025)

Abbott

13%

Oral supplements for cancer & post-op care

Piloted AI-personalized ONS in UK NHS (2024)

Others (Baxter, B. Braun, regional players)

28%

Pediatric, diabetes nutrition, hospital tenders

Localization efforts across CEE and Iberia

 

Market Segmentation
By Route of Administration:

  • Enteral Nutrition (EN) – 53%
  • Parenteral Nutrition (PN) – XX%
  • Oral Nutritional Supplements (ONS) – XX%

 

By End User:

  • Hospitals and Acute Care Centers – 50%
  • Home Healthcare & Long-Term Care – XX%
  • Specialized Outpatient Clinics – XX%

 

Regional Spotlight

  • Germany & France – Lead in ICU- and post-surgical nutrition protocols
  • UK – National malnutrition screening implementation in NHS; digital dietetic tools scaling
  • Italy & Spain – Growth in cancer and elderly home nutrition programs

 

Recent Developments

  • Danone launched Nutrison Renal Advance for hospital and home renal patients (2024)
  • Fresenius introduced EU-certified triple-chamber PN bags for ICU patients
  • Nestlé deployed MySupport+ remote nutrition adherence app across EU5 (Q2 2025)

 

Strategic Outlook:

European health systems must ensure seamless nutritional support across both acute and home settings. Digital dietetic solutions, localized production of therapeutic blends, and unified EU reimbursement policies are essential for long-term adoption and access.

Unlock the executive summary.
Request the sample to review key questions answered.
See what’s included.
Request sample for scope, definitions and segmentation.

Key Players

  • estlé Health Science
  • Danone Nutricia
  • Abbott Laboratories 
  • Fresenius Kabi AG  
  • B. Braun Melsungen AG  
  • Baxter International Inc.
  • Reckitt Benckiser Group plc 
  • Otsuka Holdings Co., Ltd.  
  • Bayer AG
  • Pfizer Inc.
  • Mead Johnson & Company, LLC  
  • BASF SE
  • Perrigo Company plc  
  • DSM 
  • Nutricia Advanced Medical Nutrition 
Competitive Dashboard Preview
Shortlist strategic accounts and benchmark positioning.
Loading…
Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.
Refine View
Opportunity Index
Directional signals for prioritization and scenario framing.
Interactive
Need a board-ready slide? .
Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Table Of Contents

Expandable preview of coverage and chapter structure.

Clinical Nutrition Market Report


 

  1. 1. Clinical Nutrition Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Clinical Nutrition Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Clinical Nutrition Market Research Report - Preface
    1. 2.1 Clinical Nutrition Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Route of Administration:
      2. 2.1.2 By End User:
      3. 2.1.3 By Region
  3. 3. Clinical Nutrition Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Route of Administration:, By End User:, By Country
    3. 3.3. Opportunities – By Route of Administration:, By End User:, By Country
    4. 3.4. Trends – By Route of Administration:, By End User:, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Clinical Nutrition Market Research Report – DROTs Impact Analysis
    1. 4. Clinical Nutrition Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Clinical Nutrition Market, By Route of Administration:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Enteral Nutrition (EN)
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Parenteral Nutrition (PN)
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Oral Nutritional Supplements (ONS)
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Clinical Nutrition Market, By End User:, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Hospitals and Acute Care Centers
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Home Healthcare & Long-Term Care
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Specialized Outpatient Clinics
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 7. Clinical Nutrition Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Europe
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.2 Clinical Nutrition Market - Opportunity Analysis Index, By Route of Administration:, By End User:, and Region, 2024 - 2031
  1. 8. Europe Clinical Nutrition Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 By Route of Administration: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.1.1 Enteral Nutrition (EN)
      2. 8.1.2 Parenteral Nutrition (PN)
      3. 8.1.3 Oral Nutritional Supplements (ONS)
      8.2 By End User: Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.2.1 Hospitals and Acute Care Centers
      2. 8.2.2 Home Healthcare & Long-Term Care
      3. 8.2.3 Specialized Outpatient Clinics
      8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.3.1 Germany
      2. 8.3.2 United Kingdom
      3. 8.3.3 France
      4. 8.3.4 Spain
      5. 8.3.5 Italy
      6. 8.3.6 Russia
    2. 8.4 Europe Clinical Nutrition Market – Opportunity Analysis Index, By Route of Administration:, By End User:, and Country, 2024 - 2031
    3. 8.5 Regional Trends Analysis
    4. 8.6 Europe Clinical Nutrition Market Research Report - Company Profiles
      1. 8.6.1 Company 1 (Germany)
      2. 8.6.2 Company 2 (United Kingdom)
      3. 8.6.3 Company 3 (United Kingdom)
    9. Competition Landscape
    1. 9.1 Strategic Dashboard of Top Market Players
    2. 9.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 9.2.1 Nestlé Health Science
      2. 9.2.2 Danone Nutricia
      3. 9.2.3 Abbott Laboratories
      4. 9.2.4 Fresenius Kabi AG
      5. 9.2.5 B. Braun Melsungen AG
      6. 9.2.6 Baxter International Inc.
      7. 9.2.7 Reckitt Benckiser Group plc
      8. 9.2.8 Otsuka Holdings Co. Ltd.
      9. 9.2.9 Bayer AG
      10. 9.2.10 Pfizer Inc.
      11. 9.2.11 Mead Johnson & Company LLC
      12. 9.2.12 BASF SE
      13. 9.2.13 Perrigo Company plc
      14. 9.2.14 DSM Nutritional Products
      15. 9.2.15 Nutricia Advanced Medical Nutrition
  1. 10. Data Collection Method and Research Approach
  2. 11. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
Book A Consultation
Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.
Ready to move from data to decision?
Get the report, request a sample, or book a consultative briefing.
New chat message received
×

Need help?

Chat with our team in a minute.